Trades on 1 secondary market
Contraline
Contraline is a clinical-stage biotechnology company developing non-hormonal, long-acting, reversible contraceptive options for men and couples. Its lead product, ADAM, is an investigational implant designed to provide long-lasting reversible contraception, and NES/T is a daily topical gel intended
Contraline is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.